A method of treating a systemic disease

Details for Australian Patent Application No. 2004222312 (hide)

Owner Kos Life Sciences, Inc.

Inventors Sexton, Frederick; Genova, Perry; Zhu, Yaping; Adjei, Akwete

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004222312

PCT Pub. Number WO2004/082633

Priority 10/391,053 18.03.03 US

Filing date 18 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 29 November 2007

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61M 11/00 (2006.01) Sprayers

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/082633 Priority application(s): WO2004/082633

29 November 2007 Application Accepted

  Published as AU-B-2004222312

3 April 2008 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222317-Ligands for TGF-beta binding proteins and uses thereof

2004222310-Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2